Molecular Targets in Pulmonary Fibrosis: The Myofibroblast in Focus
作者： Chris J. Scotton , Rachel C. Chambers
关键词: Medicine 、 Pulmonary fibrosis 、 Myofibroblast 、 Fibrosis 、 Epithelial–mesenchymal transition 、 Idiopathic pulmonary fibrosis 、 Stem cell 、 Interstitial lung disease 、 Lung 、 Immunology
摘要: … Decorin attenuates fibrotic progression in animal models 72 ; … ) Rapamycin treatment significantly attenuated lung collagen … neutralizing antibody directed against CTGF (FG-3019 from …
sci-hub.se 参考文章(81)
Richard Bucala, Lori A. Spiegel, Jason Chesney, Margaret Hogan, Anthony Cerami, Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Molecular Medicine. ,vol. 1, pp. 71- 81 ,(1994) , 10.1007/BF03403533
Brigham C. Willis, Janice M. Liebler, Katherine Luby-Phelps, Andrew G. Nicholson, Edward D. Crandall, Roland M. du Bois, Zea Borok, Induction of Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells by Transforming Growth Factor-β1 : Potential Role in Idiopathic Pulmonary Fibrosis American Journal of Pathology. ,vol. 166, pp. 1321- 1332 ,(2005) , 10.1016/S0002-9440(10)62351-6
Jill E. Kolodsick, Galen B. Toews, Claudia Jakubzick, Cory Hogaboam, Thomas A. Moore, Andrew McKenzie, Carol A. Wilke, Cara J. Chrisman, Bethany B. Moore, Protection from Fluorescein Isothiocyanate-Induced Fibrosis in IL-13-Deficient, but Not IL-4-Deficient, Mice Results from Impaired Collagen Synthesis by Fibroblasts Journal of Immunology. ,vol. 172, pp. 4068- 4076 ,(2004) , 10.4049/JIMMUNOL.172.7.4068
Huw Richard H R Davies, Luca Richeldi, E. Haydn Walters, Immunomodulatory agents for idiopathic pulmonary fibrosis Cochrane Database of Systematic Reviews. ,(2003) , 10.1002/14651858.CD003134
Sem H. Phan, David Gordon, Mark D. Rekhter, Kai Zhang, Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study American Journal of Pathology. ,vol. 145, pp. 114- 125 ,(1994)
Luca Richeldi, Huw Richard H R Davies, Paolo Spagnolo, Fabrizio Luppi, Corticosteroids for idiopathic pulmonary fibrosis Cochrane Database of Systematic Reviews. ,(2003) , 10.1002/14651858.CD002880
Harold R. Collard, Jay H. Ryu, William W. Douglas, Marvin I. Schwarz, Douglas Curran-Everett, Talmadge E. King, Kevin K. Brown, Combined Corticosteroid and Cyclophosphamide Therapy Does Not Alter Survival in Idiopathic Pulmonary Fibrosis Chest. ,vol. 125, pp. 2169- 2174 ,(2004) , 10.1378/CHEST.125.6.2169
Philippe Bonniaud, Peter J. Margetts, Martin Kolb, Thomas Haberberger, Margaret Kelly, Jennifer Robertson, Jack Gauldie, Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosis. American Journal of Respiratory and Critical Care Medicine. ,vol. 168, pp. 770- 778 ,(2003) , 10.1164/RCCM.200210-1254OC
Jeremy T. Allen, Richard A. Knight, Claire A. Bloor, Monica A. Spiteri, Enhanced Insulin-Like Growth Factor Binding Protein–Related Protein 2 (Connective Tissue Growth Factor) Expression in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis American Journal of Respiratory Cell and Molecular Biology. ,vol. 21, pp. 693- 700 ,(1999) , 10.1165/AJRCMB.21.6.3719
Edward B. Leof, Andrew H. Limper, Craig E. Daniels, Stephen J. Murphy, Maryanne Edens, Ted J. Kottom, Mark C. Wilkes, Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis Journal of Clinical Investigation. ,vol. 114, pp. 1308- 1316 ,(2004) , 10.1172/JCI19603